The University of Minnesota Medical School has developed a therapeutic vaccine for opioid use disorder that is the subject of a new Phase 1 randomized placebo-controlled clinical trial. The trial, which recently begun enrollment, will be conducted at the Columbia University Irving Medical Center in New York. Sandra Comer, a professor of neurobiology at the College of Physicians and…